Monarch Partners Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.16M | Buy |
179,129
+363
| +0.2% | +$8.42K | 1.23% | 19 |
|
|
2022
Q3 | $2.86M | Buy |
178,766
+23,465
| +15% | +$376K | 0.86% | 43 |
|
|
2022
Q2 | $2.75M | Buy |
155,301
+75,226
| +94% | +$1.33M | 0.77% | 54 |
|
|
2022
Q1 | $1.63M | Hold |
80,075
| – | – | 0.36% | 122 |
|
|
2021
Q4 | $1.5M | Buy |
80,075
+6,776
| +9% | +$127K | 0.3% | 137 |
|
|
2021
Q3 | $1.45M | Buy |
73,299
+7,104
| +11% | +$140K | 0.21% | 135 |
|
|
2021
Q2 | $1.57M | Buy |
66,195
+25,090
| +61% | +$593K | 0.23% | 129 |
|
|
2021
Q1 | $974K | Sell |
41,105
-1,215
| -3% | -$28.8K | 0.15% | 136 |
|
|
2020
Q4 | $848K | Sell |
42,320
-25,835
| -38% | -$518K | 0.15% | 152 |
|
|
2020
Q3 | $1.42M | Buy |
68,155
+21,970
| +48% | +$457K | 0.32% | 91 |
|
|
2020
Q2 | $808K | Buy |
46,185
+18,740
| +68% | +$328K | 0.2% | 108 |
|
|
2020
Q1 | $448K | Buy |
+27,445
| New | +$448K | 0.16% | 119 |
|
|
2019
Q2 | – | Sell |
-33,770
| Closed | -$511K | – | 171 |
|
|
2019
Q1 | $511K | Hold |
33,770
| – | – | 0.08% | 153 |
|
|
2018
Q4 | $580K | Buy |
33,770
+5,430
| +19% | +$93.3K | 0.08% | 141 |
|
|
2018
Q3 | $418K | Buy |
28,340
+6,000
| +27% | +$88.5K | 0.04% | 183 |
|
|
2018
Q2 | $533K | Hold |
22,340
| – | – | 0.05% | 173 |
|
|
2018
Q1 | $571K | Buy |
22,340
+8,060
| +56% | +$206K | 0.05% | 160 |
|
|
2017
Q4 | $264K | Buy |
+14,280
| New | +$264K | 0.02% | 181 |
|